Veiga Fernanda Rangel da, Russomano Fábio Bastos, Camargo Maria José de, Monteiro Aparecida Cristina Sampaio, Tristão Aparecida, Silva Gabriela Villar e
Instituto Fernandes Figueira, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Sao Paulo Med J. 2009 Sep;127(5):266-9. doi: 10.1590/s1516-31802009000500004.
Cervical cancer is a serious public health problem in Brazil. For patients with unsatisfactory colposcopic examinations without visible lesions, but with cervical cytological tests suggesting high-grade squamous intraepithelial lesion (HSIL), the national recommendation is to repeat cervical cytological tests after three months. Our aim was to assess the prevalence of HSIL and cancer among patients with initial cervical cytological tests suggestive of HSIL but with unsatisfactory colposcopic examinations without visible lesions, in order to contribute towards the discussion regarding a more effective clinical approach that might diminish the likelihood of patient abandonment of follow-up before appropriate diagnosis and treatment.
Cross-sectional study in Colposcopy Clinic of IFF/Fiocruz.
Patients admitted between December 1989 and April 2007 with cytological diagnoses of HSIL but with unsatisfactory colposcopic examinations without visible lesions underwent cervical cone biopsy.
Sixty-five such patients were included, comprising 33.8% with HSIL and 4.6% with cancer, confirmed histologically. The other patients presented low-grade squamous intraepithelial lesion (26.1%), glandular dysplasia (1.5%) and absence of disease (33.8%).
The observed prevalence of cancer and HSIL does not seem to be enough to justify immediate referral for cone biopsies to investigate the cervical canal in these cases. The findings suggest that the recommendation of repeated cytological tests following an initial one with HSIL, among patients with unsatisfactory colposcopic examinations without visible lesions, is appropriate in our setting. Efforts are needed to ensure adherence to follow-up protocols in order to reduce the chances of losses.
宫颈癌在巴西是一个严重的公共卫生问题。对于阴道镜检查结果不理想且无可见病变,但宫颈细胞学检查提示高级别鳞状上皮内病变(HSIL)的患者,巴西的国家建议是在三个月后重复进行宫颈细胞学检查。我们的目的是评估最初宫颈细胞学检查提示HSIL但阴道镜检查结果不理想且无可见病变的患者中HSIL和癌症的患病率,以便为有关更有效临床方法的讨论提供参考,这种方法可能会降低患者在进行适当诊断和治疗之前放弃随访的可能性。
在IFF/Fiocruz阴道镜诊所进行的横断面研究。
对1989年12月至2007年4月期间因细胞学诊断为HSIL但阴道镜检查结果不理想且无可见病变而入院的患者进行宫颈锥切活检。
纳入了65例此类患者,其中组织学确诊为HSIL的占33.8%,癌症患者占4.6%。其他患者表现为低级别鳞状上皮内病变(26.1%)、腺体发育异常(1.5%)和无疾病(33.8%)。
观察到的癌症和HSIL患病率似乎不足以证明在这些病例中立即转诊进行锥切活检以检查宫颈管是合理的。研究结果表明,对于阴道镜检查结果不理想且无可见病变的患者,在最初细胞学检查提示HSIL后建议重复进行细胞学检查,在我们的研究环境中是合适的。需要努力确保患者遵守随访方案,以减少失访的可能性。